The Babraham Distinguished Seminar Series is sponsored by the Babraham Â鶹ÊÓƵ and the Babraham Research Campus which is home to more than 50 biotech companies. The seminars are also advertised to the wider Cambridge community. The series will provide exciting science talks by distinguished scientists from across the world in many areas of biomedical interest.
Linda Partridge works on the biology of ageing. Her research is directed to understanding the mechanisms by which the healthy period of life can be extended in laboratory model organisms and in humans. She has focussed on the role of the nutrient-sensing signalling network and of diet. Her primary current interest is in the potential to repurpose drugs for geroprotection. She is the recipient of numerous awards. She is a Fellow of the Royal Society, the Academy of Medical Sciences and a foreign member of the American Academy of Arts and Sciences and the German Academy of Sciences Leopoldina. She is the emeritus founding director of the Max Planck Â鶹ÊÓƵ for Biology of Ageing in Cologne, Germany.
Mechanisms of ageing are present in the aetiology of human age-related diseases. Indeed, hallmarks of ageing can partially explain disease co-occurrence in humans. There is marked inequality in heath during ageing. Obesity and social deprivation both accelerate the incidence of diseases associated with specific ageing hallmarks. These findings support the geroscience hypothesis, that human health during ageing could be improved by targeting mechanisms of ageing with drugs. We have been investigating two potentially geroprotective drugs, rapamycin and trametinib, and find that they are especially powerful in combination, in both Drosophila and mice. Reduced inflammation appears to play a prominent role, and warrants more detailed study.
Following the talk there will be networking tea, coffee and cake
Event Time & Dates
Event Details